Clinical Trial Update: Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia) [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study of lamivudine in HBeAg-negative chronic hepatitis B patients in Asia and confirms the study status as compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Lamivudine (lamivudine)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED